SKYE (Skye Bioscience) FFO


SKYE Skye Bioscience Inc SKYE
30 GF Score
Price $0.71
! 1 Warning Sign
View Full Analysis

What is Skye Bioscience FFO?

FFO (Funds from operations) only applies to REITs.

SKYE
30GF Score
Skye Bioscience Inc SKYE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Skye Bioscience Business Description

Other Exchanges 09R:Germany
Address 11250 El Camino Real, Suite 100, San Diego, CA, USA, 92130
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
30GF Score

Get the complete analysis for SKYE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.71
Price